A new aldosterone synthase inhibitor added to SGLT2 inhibitors reduces uncontrolled blood pressure in patients with chronic kidney disease, according to the results of a phase 2 trial.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/novel-aldosterone-synthase-inhibitor-lorundrostat-shows-2025a1000v60?src=rss
Author :
Publish date : 2025-11-10 21:50:00
Copyright for syndicated content belongs to the linked Source.
